Dr Kimberly Janne Wonderlich, MD | |
2775 College Road, Fairbanks, AK 99709 | |
(907) 456-1979 | |
(907) 456-1903 |
Full Name | Dr Kimberly Janne Wonderlich |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 20 Years |
Location | 2775 College Road, Fairbanks, Alaska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346211505 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 23558 (Nebraska) | Secondary |
207N00000X | Dermatology | 8102 (Alaska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Fairbanks Memorial Hospital | Fairbanks, AK | Hospital |
Entity Name | Kimberly J Wonderlich Md Faad Dermatology Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396124897 PECOS PAC ID: 2365759727 Enrollment ID: O20150916003404 |
News Archive
A University of Southern California study appearing in the current issue of peer-review journal, Nutrition Research reports that the user-friendly, Web-native Stayhealthy BC1 System offers clinical-grade body composition analysis comparable to the most rigorous clinical tools. According to the company, the study's findings open the door to a new, far more effective and engaging model for health and fitness measurement, reporting body composition analysis, rather than body weight or the outdated body mass index.
In response to a U.S. shortage of a vaccine to protect infants from Haemophilus influenzae type b (Hib), GlaxoSmithKline (NYSE: GSK) has received accelerated approval from the FDA (Food and Drug Administration) for Hiberix((R)) [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] as a booster dose in children 15 months through four years of age. Hib is an often severe and potentially deadly bacterial infection that can cause meningitis.
An international research team including Vasiliy Ramensky, a member of the MIPT Life Sciences Center, has unraveled genetic characteristics that increase the risk of developing Tourette syndrome.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has priced an underwritten public offering of 39,200,000 shares of common stock and warrants to purchase up to 39,200,000 shares of common stock at a combined public offering price of $0.52 per share and related warrant for gross proceeds of approximately $20.4 million.
New research indicates that children with autism who are minimally verbal can learn to speak later than previously thought, and iPads are playing an increasing role in making that happen, according to Ann Kaiser[peabody.vanderbilt.edu], a researcher at Vanderbilt Peabody College[peabody.vanderbilt.edu] of education and human development.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kimberly Janne Wonderlich, MD 2775 College Road, Fairbanks, AK 99709 Ph: (907) 456-1979 | Dr Kimberly Janne Wonderlich, MD 2775 College Road, Fairbanks, AK 99709 Ph: (907) 456-1979 |
News Archive
A University of Southern California study appearing in the current issue of peer-review journal, Nutrition Research reports that the user-friendly, Web-native Stayhealthy BC1 System offers clinical-grade body composition analysis comparable to the most rigorous clinical tools. According to the company, the study's findings open the door to a new, far more effective and engaging model for health and fitness measurement, reporting body composition analysis, rather than body weight or the outdated body mass index.
In response to a U.S. shortage of a vaccine to protect infants from Haemophilus influenzae type b (Hib), GlaxoSmithKline (NYSE: GSK) has received accelerated approval from the FDA (Food and Drug Administration) for Hiberix((R)) [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] as a booster dose in children 15 months through four years of age. Hib is an often severe and potentially deadly bacterial infection that can cause meningitis.
An international research team including Vasiliy Ramensky, a member of the MIPT Life Sciences Center, has unraveled genetic characteristics that increase the risk of developing Tourette syndrome.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has priced an underwritten public offering of 39,200,000 shares of common stock and warrants to purchase up to 39,200,000 shares of common stock at a combined public offering price of $0.52 per share and related warrant for gross proceeds of approximately $20.4 million.
New research indicates that children with autism who are minimally verbal can learn to speak later than previously thought, and iPads are playing an increasing role in making that happen, according to Ann Kaiser[peabody.vanderbilt.edu], a researcher at Vanderbilt Peabody College[peabody.vanderbilt.edu] of education and human development.
› Verified 2 days ago